Yukinao Yamauchi

INVOLVEMENT OF INCREASED ARGINASE ACTIVITY IN IMPAIRED CAVERNOUS RELAXATION WITH AGING IN THE RABBIT

Yasuyuki Sakai, Hitoshi Masuda, Kazunori Kihara et al. · The Journal of Urology · 2004 · 39 citations

Elevation of tissue cathepsin B and L activities in gastric cancer.

Makoto Watanabe, Tomohiro Higashi, Makoto Hashimoto et al. · PubMed · 1987 · 27 citations

Gastrointestinal Pharmacology, Immunology, Gastroenterology +18

Discovery of a Novel 5-HT₃ Antagonist/5-HT_1A Agonist 3-Amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3<i>H</i>)-one (TZB-30878) as an Orally Bioavailable Agent for Irritable Bowel Syndrome

Akira Asagarasu, Teruaki Matsui, Hiroyuki Hayashi et al. · Journal of Medicinal Chemistry · 2010 · 24 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Allergy +13

Design and Synthesis of Piperazinylpyridine Derivatives as Novel 5-HT1A Agonists/5-HT3 Antagonists for the Treatment of Irritable Bowel Syndrome (IBS)

Akira Asagarasu, Teruaki Matsui, Hiroyuki Hayashi et al. · Chemical and Pharmaceutical Bulletin · 2009 · 24 citations · Full text

Serotonin Subtype 1A, Medicinal Chemistry, Functional Gastrointestinal Disorder +11

Pharmacological Properties of 3-Amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3 H)-one (TZB-30878), a Novel Therapeutic Agent for Diarrhea-Predominant Irritable Bowel Syndrome (IBS) and Its Effects on an Experimental IBS Model

Satoru Tamaoki, Yukinao Yamauchi, Youichi Nakano et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 24 citations